observed that high levels of TGF‐β in TME in CRC induced a weak immune response and that blocked TGF‐β in TME could enhance the effect of PD‐1 or PD‐L1 immunotherapy and decrease metastasis in a mouse model. The gene discussed is TGFB1; the disease is colorectal carcinoma.